Realfiction Holding AB Board of Directors Initiates Strategic Review to Strengthen Commercialization of DPT Technology
The Board of Directors of Realfiction Holding AB (“Realfiction” or the “Company”) has decided to initiate a strategic process with the aim to strengthening the commercialization of DPT technology, by exploring and evaluating the interest and conditions for a potential industrial partnership, joint venture, or other strategic combination involving the Company, including to explore any interest by potential acquirers of the Company and/or its subsidiaries.
The decision is based on an overall assessment of the Company’s long-term development opportunities and is intended to ensure the best possible conditions for accelerating commercialization, mass production, and global sales of the Company’s DPT technology.
The Board believes that a structural solution could potentially strengthen the Company’s market position, accelerate the scaling of the technology, and create increased value for shareholders. The process will include an evaluation of relevant strategic alternatives and potential interested parties.
No decision has been made at this time, and there can be no assurance that the process will result in any partnership, transaction or offer for the Company. The Company will continuously assess its options and will inform the market in accordance with applicable regulations should any material developments occur.
The Company’s day-to-day operations, activities, and strategic priorities will continue unchanged while the strategic review is ongoing.